Beranda › Diabetes Tipe 2 › New York
Uji klinis Diabetes Tipe 2 di New York
33 studi untuk Diabetes Tipe 2 mencari peserta di lokasi di New York.
Kota di New York
- New York City16 studi
- Brooklyn7 studi
- The Bronx6 studi
- Syracuse5 studi
- Buffalo5 studi
- Manhattan3 studi
- Cheektowaga3 studi
- Albany3 studi
Teks studi resmi (Bahasa Inggris)
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
- State University of New York at Buffalo, South Campus, Buffalo
Menerima peserta
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07641361A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Rochester Clinical Research - Buffalo, Buffalo
- CHEAR Center LLC, The Bronx
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Albany Med Health System - Washington Avenue Extension, Albany
- Velocity Clinical Research - Binghamton, Binghamton
- RCR - Buffalo, Buffalo
- dan 7 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Ellipsis Research Group - Brooklyn, Brooklyn
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Clindove Research, Brooklyn
- Swift Clinical Research, Brooklyn
- Rasaj Research, Jackson Heights
- dan 4 lainnya
Menerima pesertaSukarelawan sehat diterima
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Weill Cornell Medicine - Comprehensive Weight Control Center, New York
- Rochester Clinical Research, LLC, Rochester
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07595549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NYC Research INC, Long Island City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, East Northport
- AURORA-2 Clinical Site, East Syracuse
- AURORA-2 Clinical Site, New Windsor
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes
- NYU Langone Health, New York
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06319716A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Brooklyn Clinical Research, Brooklyn
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07340320A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- NYC Research INC, Long Island City
- Richmond University Medical Center, Staten Island
- Southgate Medical Group, West Seneca
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06897475Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Velocity Clinical Research, Binghamton
- CHEAR Center LLC, The Bronx
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07271186Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Albany Medical College, Albany
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07296484A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- UBMD Pediatrics, Buffalo
- NYU Langone Orthopedic Center, New York
Menerima pesertaFase 3
Usia 10 hingga 18 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07282613Graded Insulin Suppression Test P&F
- Columbia University Irving Medical Center, New York
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06592261Alpelisib Challenge Test (ACT)
- Columbia University Irving Medical Center, New York
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07778524A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, The Bronx
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Central New York Clinical Research CNYCR, Manlius
- Mid Hudson Med Res-New Windsor, New Windsor
- Harlem Cardiology_Madison ave, New York
- dan 3 lainnya
Menerima pesertaFase 3
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Brooklyn
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07662109Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- SUNY Upstate Medical Center, Albany
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599982APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
- Weill Cornell Medicine, New York
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07773779A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- WBMD Pediatrics, Buffalo
- Cohen Children's Medical Center Division of Pediatric Endocrinology, Hyde Park
- SUNY Upstate Medical University, Syracuse
Menerima pesertaFase 3
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06739122Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- The Mount Sinai Hospital, New York
- SUNY Syracuse, Syracuse
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07521475Milk for Diabetes Prevention
- HCHS/SOL Bronx Field Center, The Bronx
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 26 Mei 2026 · NCT06513026ED Diabetes Screening and Outpatient Care - Aim 3
- NYU Langone Health, New York
Menerima peserta
Usia 20 hingga 70 · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT05899023DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- NYU Langone Health- Brooklyn, Brooklyn
- NYU Langone Health- Long Island, Garden City
- NYU Langone Health- Manhattan, New York
- dan 1 lainnya
Menerima pesertaStudi observasional
Usia 8 hingga 15 · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT06525259Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
- NYU Langone Health, New York
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 9 Mar 2026 · NCT06319703High Fructose Diet, the Gut Microbiome, and Metabolic Health
- Mount Sinai Morningside, New York
Menerima pesertaSukarelawan sehat diterima
Usia 25 hingga 45 · Semua jenis kelamin · Diperbarui 17 Des 2025 · NCT06329544Effects of HIIT vs. TRE on Type 2 Diabetes Risk
- Syracuse University, Syracuse
Menerima pesertaSukarelawan sehat diterima
Usia 14 hingga 30 · Semua jenis kelamin · Diperbarui 10 Okt 2025 · NCT07215533Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- Clindove Research LLC, Brooklyn
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT07106879NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Menerima pesertaStudi observasional
30 Days · Semua jenis kelamin · Diperbarui 3 Mar 2025 · NCT06203106RESET System Pivotal Trial (Rev F)
- Weill Cornell Medicine, New York
Menerima peserta
Usia 22 hingga 65 · Semua jenis kelamin · Diperbarui 18 Jul 2024 · NCT04101669Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
- Brooklyn Clinical Research, Brooklyn
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2024 · NCT06412536Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.